Answers are grounded in this paper and cite their sources.
Luigi Gargiulo, Antonio Costanzo; Age of Onset Matters: Tildrakizumab Response in Early vs Late-Onset Psoriasis, British Journal of Dermatology, , ljaf186,
No takes yet. Share an insight, caveat, or question.
Gargiulo et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: